Yuri Ikeda1, Akinori Ueno1, Hiroaki Naraba1,
Norio Matsuki2 and Sachiko Oh-ishi1,*
1Department of Pharmacology, School of Pharmaceutical Sciences,
Kitasato University, 5-9-1 Shirokane, Minato-ku, Tokyo 108-8641, Japan
2Department of Pharmacology, Faculty of Pharmaceutical Sciences,
Tokyo University, 7-3-1 Hongo, Bunkyo-ku, Tokyo 113-0033, Japan
*Corresponding author.ÊÊPresent address for correspondence: Kitasato
FAX:+81-3-5791-6120, E-mail: oh-ishi@kitasato.or.jp
Abstract: Murine neuroblastoma cell line Neuro-2A cells and rat brain
astrocytes showed a dose-dependent increase in intracellular Ca2+
in response to bradykinin, when assessed by a single cell image analyzing
system. The Ca2+ increase in Neuro-2A cells by bradykinin was
also examined by a suspension fluorescent assay using fura-2 loading. The
Ca2+ increase in both cases was suppressed by a bradykininÊB2
receptor antagonist, HoeÊ140, but not by a B1 receptor antagonist,
des-Arg-HoeÊ140, suggesting that the effect occurred via specific B2
receptor activation. RT-PCR for bradykininÊB2 receptor mRNA showed
that both Neuro-2A cells and the astrocytes expressed B2 receptor
mRNA. Binding of [3H]bradykinin to Neuro-2A cells was assessed,
and a specific binding constant of 0.75ÊnM was determined. Furthermore,
the increase in [Ca2+]i by bradykinin could be caused
by a release of Ca2+ from storage sites in the endoplasmic reticulum,
since thapsigargin and U-73122 attenuated the effect of bradykinin in Neuro-2A
as well as in astrocytes. These results indicate that both astrocytes and
neuroblastoma Neuro-2A cells stimulated by bradykinin could express a bradykininÊB2
receptor-mediated intracellular Ca2+ increase leading to signal
transduction.
Keywords: Bradykinin, Neuro-2A, Astrocyte, Intracellular Ca2+,
Bradykinin B2 receptor
Copyright© The Japanese Pharmacological Society 2000
[Back to TOC]